Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone
Annals of the Child Neurology Society · 2025-06 · 3 (2) · 115-120
DOI: 10.1002/cns3.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 11.05.2025. Verfasst von Carol Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Febrile infection‐related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness. Patient Description We describe a 12‐year‐old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT‐DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT‐DEX led to rapid seizure control and significant neurological recovery.
Conclusion
This report supports IT‐DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long‐term efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
- Advocate Children's Medical Group Park Ridge Illinois USA.
- Department of Neurology University of Chicago Chicago Illinois USA.
- Department of Neurology, Comprehensive Epilepsy Center Yale University School of Medicine New Haven Connecticut USA.
- Department of Pharmacy University of Chicago Chicago Illinois USA.
Zitieren
APA
Park, C., Nordli, D. R., Taha, M., David, H., Kacker, S., Kass-Hout, T., Thind, S., Hanin, A., Said, S., Haider, H. A., & Nordli, D. R. (2025). Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone. Annals of the Child Neurology Society, 3(2), 115-120. https://doi.org/10.1002/cns3.70008
Vancouver
Park C, Nordli DR, Taha M, David H, Kacker S, Kass-Hout T, et al. Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone. Annals of the Child Neurology Society. 2025;3(2):115-120. doi:10.1002/cns3.70008
BibTeX
@article{Park2025,
author = {Park, Carol and Nordli, Douglas R and Taha, Mohamed and David, Henry and Kacker, Shawn and Kass-Hout, Tareq and Thind, Sonam and Hanin, Aurelie and Said, Sana and Haider, Hiba A and Nordli, Douglas R},
title = {Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone},
journal = {Annals of the Child Neurology Society},
year = {2025},
volume = {3},
number = {2},
pages = {115--120},
doi = {10.1002/cns3.70008}
}
EUVIMED